A detailed history of Lisanti Capital Growth, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Lisanti Capital Growth, LLC holds 299,180 shares of ADPT stock, worth $4.22 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares
299,180
Holding current value
$4.22 Million
% of portfolio
1.27%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025

BUY
$10.24 - $14.96 $3.06 Million - $4.48 Million
299,180 New
299,180 $4.48 Million

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $2.01B
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Lisanti Capital Growth, LLC Portfolio

Follow Lisanti Capital Growth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lisanti Capital Growth, LLC with notifications on news.